D46.C
Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
Clinical Classification Guidelines
Inclusion Terms
- Myelodysplastic syndrome with 5q deletion
- 5q minus syndrome NOS
Medical Intelligence & Overview
Myelodysplastic syndrome (MDS) with isolated del(5q) is a specific type of blood disorder where the bone marrow produces abnormal blood cells. This condition is characterized by the deletion of a part of chromosome 5, known as del(5q). It is considered a distinct subtype of MDS and is sometimes called 5q minus syndrome. Patients with this diagnosis often have a better prognosis compared to other types of MDS, but it still requires medical management and monitoring.
Causes & Symptoms
Clinical Causes: Genetic mutation leading to the deletion of a segment of chromosome 5 (del(5q)). Age-related changes, as MDS is more common in older adults. Environmental exposures, such as radiation or certain chemicals, can contribute but are less specific. Previous chemotherapy or radiation therapy for other cancers may increase risk.
Key Symptoms: Unusual fatigue or weakness Pale skin due to anemia Easy bruising or bleeding Frequent infections due to weakened immune defenses Shortness of breath Unexplained weight loss Fever without clear infection Pinpoint red or purple spots called petechiae
Diagnostic & Treatment
Diagnosis Path: Diagnosing myelodysplastic syndrome with isolated del(5q) involves several steps:
Treatment Protocols: Treatment options focus on managing symptoms and improving blood cell production:
Clinical Advice & FAQs
Billing Guidance
Is D46.C a billable ICD-10 code?
Yes, D46.C is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D46.C?
Clinical documentation must specify the nature of Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality and any associated comorbidities for accurate reporting.
Cite this Clinical Reference